Young innovative biotechnology company that relies on innovation from the CNRS, the company Alzohis just created. It aims to commercialize a new diagnosis of Alzheimer’s disease, in partnership with French and German hospitals.
This initiative was supported by the C’Nano IdF, including through the Seminar "Value the research by the creation of start-up", followed by President Roman Verpillot. And the Call for Project "Valo" with obtaining a coaching and a cofinancing of a prototype.
You can find more information about the company on the website of Alzohis.